VBI to Present at the CMV Public Health & Policy Conference
24 sept. 2014 10h45 HE
|
VBI Vaccines, Inc.
VBI is developing a prophylactic CMV vaccine; VBI's Senior Vice President of Research will discuss the vaccine candidate's design, preclinical data, and manufacturing process.
The...
New Data Supporting VBI's Prophylactic Cytomegalovirus (CMV) Vaccine Candidate (VBI-1501A) Presented at the 54th ICAAC Conference in Washington, D.C.
15 sept. 2014 12h30 HE
|
VBI Vaccines, Inc.
Rapid, potent, and durable immunity demonstrated with vaccine candidate (VBI-1501A).
Pilot scale (10L) production of VBI-1501A expected to meet Phase I trial release criteria.
CAMBRIDGE,...
Variation Biotechnologies and Paulson Capital Announce Completion of Merger
28 juil. 2014 08h32 HE
|
VBI Vaccines, Inc.
Paulson Capital (Delaware) Corp. Changes Name to VBI Vaccines Inc.
VBI Vaccines Inc. Shares to Trade on NASDAQ Under the Ticker Symbol "VBIV" at Market Open on Tuesday, July 29,...
Paulson Capital Announces Stockholder Approval of Contemplated Merger With Variation Biotechnologies (US)
15 juil. 2014 17h12 HE
|
VBI Vaccines, Inc.
PORTLAND, Ore., July 15, 2014 (GLOBE NEWSWIRE) -- On July 14, 2014, Paulson Capital (Delaware) Corp. (Nasdaq:PLCC) (the "Company") held a Special Meeting of Stockholders at which 67.4% of the...
Paulson Capital (Delaware) Corp. Announces Meeting Date and Record Date for the Special Meeting of Stockholders
24 juin 2014 16h50 HE
|
VBI Vaccines, Inc.
PORTLAND, Ore., June 24, 2014 (GLOBE NEWSWIRE) -- Paulson Capital (Delaware) Corp. (Nasdaq:PLCC) ("Paulson") today announced that a Special Meeting of Stockholders will be held on July 14, 2014, at...
Paulson Capital and Variation Biotechnologies Enter Into Merger Agreement
09 mai 2014 08h30 HE
|
VBI Vaccines, Inc.
PORTLAND, Ore., May 9, 2014 (GLOBE NEWSWIRE) -- Paulson Capital (Delaware) Corp., a publicly traded Delaware corporation (Nasdaq:PLCC) ("Paulson"), and privately owned Variation Biotechnologies (US),...
Paulson Capital Corp. to Remain Listed on NASDAQ; Receives Letter of Reprimand
20 févr. 2014 09h00 HE
|
VBI Vaccines, Inc.
PORTLAND, Ore., Feb. 20, 2014 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq:PLCC) (the "Company") today announced that on February 19, 2014, it was notified that, following a hearing on February...
Paulson Capital Corp. Announces Changes to Its Board of Directors
28 janv. 2014 17h00 HE
|
VBI Vaccines, Inc.
PORTLAND, Ore., Jan. 28, 2014 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq:PLCC) (the "Company") today announced the appointment of Alan P. Timmins to its Board and Audit Committee. Mr. Timmins...
Paulson Capital Corp. Announces Shares to Resume Trading Pending Hearing Disposition; Issuance of and Intention to Appeal NASDAQ Determination Letter; and Appointment of Independent Director
06 janv. 2014 17h59 HE
|
VBI Vaccines, Inc.
PORTLAND, Ore., Jan. 6, 2014 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq:PLCC) (the "Company") today announced that it is expected that, effective on January 8, 2014, the Company's common stock...
Paulson Capital Corp. Announces Meeting Date and Record Date for the 2013 Annual Meeting of Shareholders
27 sept. 2013 13h32 HE
|
VBI Vaccines, Inc.
PORTLAND, Ore., Sept. 27, 2013 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq:PLCC) (the "Company") today announced that its 2013 Annual Meeting of Shareholders will be held on November 8, 2013....